Merck Regroups On Mevacor Switch; Will CUSTOM Analysis Pave The Way?
J&J/Merck joint venture is working to solve self-selection issues that led to an FDA “not approvable” decision on the OTC switch application for the statin in 2005.
J&J/Merck joint venture is working to solve self-selection issues that led to an FDA “not approvable” decision on the OTC switch application for the statin in 2005.